SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-000968
Filing Date
2023-01-05
Accepted
2023-01-05 16:06:09
Documents
3
Period of Report
2022-12-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7718
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4022
3 EX-24.2 DOCUMENT attachment2.htm EX-24.2 4014
  Complete submission text file 0000899243-23-000968.txt   17917
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address NIHONBASHI-HONCHO YS BLDG 3F 2-2-2 NIHONBASHI-HONCHO, CHUO-KU TOKYO M0 103-0023
Business Address NIHONBASHI-HONCHO YS BLDG 3F 2-2-2 NIHONBASHI-HONCHO, CHUO-KU TOKYO M0 103-0023 81-3-6214-3600
GNI Group Ltd. (Reporting) CIK: 0001958461 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51173 | Film No.: 23511297

Mailing Address 12/F ELITE CENTRE 22 HUNG TO ROAD KWUN TONG KL K3 0000
Business Address 12/F ELITE CENTRE 22 HUNG TO ROAD KWUN TONG KL K3 0000 81-3-6214-3600
GNI Hong Kong Ltd (Reporting) CIK: 0001958509 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51173 | Film No.: 23511296